[Reperfusion and potential damages in heart surgery].
Feindt
P
P
Klinik für Thorax- und Kardiovaskulare Chirurgie, Chirurgische Universitätsklinik, Heinrich Heine-Universität Düsseldorf, Düsseldorf. peter.feindt@uni-duesseldorf.de
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D006348:Cardiac Surgical Procedures; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000503:physiopathology / Q000601:surgery; D006324:Heart Arrest, Induced; D006355:Heart-Lung Machine; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood; D009203:Myocardial Infarction / Q000503:physiopathology / Q000601:surgery; D015428:Myocardial Reperfusion Injury / Q000188:drug therapy / Q000503:physiopathology*; D011183:Postoperative Complications / Q000188:drug therapy / Q000503:physiopathology*; D012643:Selenium / Q000097:blood; D018036:Selenium Compounds / Q000627:therapeutic use; D018746:Systemic Inflammatory Response Syndrome / Q000503:physiopathology; D016896:Treatment Outcome
D000975:Antioxidants; D018836:Inflammation Mediators; D018036:Selenium Compounds; D012643:Selenium